NCT06823817Completed
Quality Control of Colposcopy Application
Quality Control of Colposcopy Application: a Retrospective Cohort Study in China
Source: ClinicalTrials.gov · Last updated 12 Feb 2025
Brief summary (registry, in English)
Colposcopy has become an important link and tool in the prevention and treatment of cervical cancer. The quality and pathological assessment of colposcopy is a key point in follow-up and treatment.The main purpose of this study was to analyze the correlation between colposcopy indications and pathological findings.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 10000 (actual)
- First submitted
- 25 Jan 2025
- Start date
- 1 Jan 2015
- Primary completion date
- 1 Jan 2025
- Lead sponsor
- Peking Union Medical College Hospital
- Diseases
- Cervical cancer
- NCT number
- NCT06823817
What you commit to
- Study type: Observational
- Participants enrolled: 10000
- From 1 Jan 2015 to the primary completion date, 1 Jan 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other conditions deemed inappropriate by the investigator to participate in this study.
Age
- Under 18 years of age;
Other
- Lack of colposcopic reports;
- Lack of cervical biopsy pathology results;
Who the study is looking for
- at least 18 years of age;
- Complete colposcopy report;
- Clear pathological diagnosis was reported after colposcopic biopsy.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.